The invention is directed to prepare medicaments for treatment of and to methods to treat conditions mediated by kinase using compounds of the formula (3) wherein Ar<1> and Ph are limited to specific embodiments or wherein the compound of formula (3) is a compound set forth in Figures 1A-1I.
